Transforming Spine Surgery Through Personalized Solutions
Our mission is to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. The Carlsmed aprevo® personalized surgery platform is designed to improve the standard of care for spine surgery one patient at a time.
Advancing what’s possible through personalized spinal solutions
Each device is tailored to the individual patient –
explore why patients want personalized care and how it makes a difference.
Latest Investor News
- February 11, 2026Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
CARLSBAD, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its fourth quarter and full year 2025 financial results after market close on Wednesday,
- February 10, 2026Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure
CARLSBAD, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the successful completion of the first posterior lumbar spine surgery using the Company’s aprevo ® Lumbar Bi-lateral Posterior System.
- January 12, 2026Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025
Fourth quarter 2025 revenue of ~$15.2 million, representing ~61% growth over Q4 2024 Full Year 2025 revenue of ~$50.5 million; representing ~86% growth over 2024 CARLSBAD, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology
